**Headline:** UK Company Vesalic Limited Identifies Potential Non-CNS Driver of Motor Neuron Diseases and Develops New Therapeutic Approach
Vesalic Limited, a UK-based biotechnology firm, has announced the discovery of a systemic metabolic dysfunction that may contribute to motor neuron diseases, including amyotrophic lateral sclerosis (ALS). The dysfunction produces toxic exosome cargo in patients, which is transported to the central nervous system (CNS) where it interacts with and damages …